Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 426

1.

Prevalence and risk factors of actinic keratosis in patients attending Italian dermatology clinics.

Fargnoli MC, Altomare G, Benati E, Borgia F, Broganelli P, Carbone A, Chimenti S, Donato S, Girolomoni G, Micali G, Moggio E, Parodi A, Piaserico S, Pistone G, Potenza C, Puviani M, Raucci M, Vaccari S, Veglio S, Zanca A, Peris K.

Eur J Dermatol. 2017 Dec 1;27(6):599-608. doi: 10.1684/ejd.2017.3126.

PMID:
29311040
2.

Use of biological drugs in patients with psoriasis and psoriatic arthritis in Italy: Results from the PSONG survey.

Potenza MC, Peris K, Berardesca E, Bianchi L, Richetta A, Bernardini N, De Simone C, Teoli M, Zangrilli A, D'epiro S, Orsini D, Narcisi A, Chimenti S, Costanzo A.

Dermatol Ther. 2018 Jan;31(1). doi: 10.1111/dth.12565. Epub 2017 Dec 7.

PMID:
29215183
3.

Left ventricular assist device: exercise capacity evolution and rehabilitation added value.

Lamotte MX, Chimenti S, Deboeck G, Gillet A, Kacelenenbogen R, Strapart J, Vandeneynde F, Van Nooten G, Antoine M.

Acta Cardiol. 2018 Jun;73(3):248-255. doi: 10.1080/00015385.2017.1368947. Epub 2017 Aug 28.

PMID:
28847218
4.

Biosimilars for psoriasis: worldwide overview of regulatory guidelines, uptake and implications for dermatology clinical practice.

Cohen AD, Wu JJ, Puig L, Chimenti S, Vender R, Rajagopalan M, Romiti R, de la Cruz C, Skov L, Zachariae C, Young HS, Foley P, van der Walt JM, Naldi L, Prens EP, Blauvelt A.

Br J Dermatol. 2017 Dec;177(6):1495-1502. doi: 10.1111/bjd.15756. Epub 2017 Nov 27. Review.

PMID:
28646580
5.

Eruptive xanthomas and pancretitis: clinical, dermatoscopy, confocal and pathological correlation.

Saraceno R, Dattola A, Pietroleonardo L, Pitocco R, Fida M, Chimenti S.

G Ital Dermatol Venereol. 2017 Aug;152(4):394-396. doi: 10.23736/S0392-0488.16.05334-7. No abstract available.

PMID:
28621119
6.

The GENDER ATTENTION Observational Study: Gender and Hormonal Status Differences in the Incidence of Adverse Events During Cyclosporine Treatment in Psoriatic Patients.

Colombo D, Banfi G, Cassano N, Graziottin A, Vena GA, Fiori GG, Zagni E, Stingeni L, Chimenti S, Berardesca E, Micali G, Albertini G, De Simone C, Bellia G; GENDER ATTENTION study group.

Adv Ther. 2017 Jun;34(6):1349-1363. doi: 10.1007/s12325-017-0526-7. Epub 2017 Apr 21.

7.

The Efficacy of Cardiac Anti-miR-208a Therapy Is Stress Dependent.

Eding JE, Demkes CJ, Lynch JM, Seto AG, Montgomery RL, Semus HM, Jackson AL, Isabelle M, Chimenti S, van Rooij E.

Mol Ther. 2017 Mar 1;25(3):694-704. doi: 10.1016/j.ymthe.2017.01.012. Epub 2017 Feb 12.

8.

Granuloma annulare: a case treated with infliximab successfully.

Giunta A, Chiricozzi A, Cannizzaro MV, Dattola A, Ruzzetti M, Nisticò SP, Chimenti S.

G Ital Dermatol Venereol. 2017 Apr;152(2):193-195. doi: 10.23736/S0392-0488.16.05320-7. No abstract available.

PMID:
28166622
9.

Dose adjustment of biologic therapies for psoriasis in dermatological practice: a retrospective study.

Esposito M, Gisondi P, Conti A, Giunta A, Del Giglio M, Di Mercurio M, Veneziano L, Ferrucci G, Bianchi L, Chimenti S, Girolomoni G.

J Eur Acad Dermatol Venereol. 2017 May;31(5):863-869. doi: 10.1111/jdv.14145. Epub 2017 Feb 27.

PMID:
28146329
10.

The nitrobenzoxadiazole derivative MC3181 blocks melanoma invasion and metastasis.

De Luca A, Carpanese D, Rapanotti MC, Viguria TM, Forgione MA, Rotili D, Fulci C, Iorio E, Quintieri L, Chimenti S, Bianchi L, Rosato A, Caccuri AM.

Oncotarget. 2017 Feb 28;8(9):15520-15538. doi: 10.18632/oncotarget.14690.

11.

Bioelectrical impedance analysis to define an excess of body fat: evaluation in patients with psoriasis.

Galluzzo M, Talamonti M, Perino F, Servoli S, Giordano D, Chimenti S, De Simone C, Peris K.

J Dermatolog Treat. 2017 Jun;28(4):299-303. doi: 10.1080/09546634.2016.1254326. Epub 2016 Nov 10.

PMID:
27786575
12.

Increased levels of IL-17 in tear fluid of moderate-to-severe psoriatic patients is reduced by adalimumab therapy.

Chiricozzi A, Cannizzaro MV, Salandri GA, Marinari B, Pitocco R, Dattola A, Regine F, Saraceno R, Bianchi L, Chimenti S, Costanzo A.

J Eur Acad Dermatol Venereol. 2016 Nov;30(11):e128-e129. doi: 10.1111/jdv.13403. Epub 2015 Oct 19. No abstract available.

PMID:
26481299
13.

Combination therapy with etanercept in psoriasis: Retrospective analysis of efficacy and safety outcomes from real-life practice.

Babino G, Giunta A, Ruzzetti M, Sole Chimenti M, Chimenti S, Esposito M.

J Int Med Res. 2016 Sep;44(1 suppl):100-105.

14.

From patients' needs to treatment outcomes in psoriasis: Results from the 'pSORRIDI' experience.

Esposito M, Faleri S, Babino G, Messinese S, Mazzotta A, Schipani C, Chimenti MS, Marchei M, Rizza S, Pandolfi M, Chimenti S, Giunta A.

J Int Med Res. 2016 Sep;44(1 suppl):95-99.

15.

Influence of body mass index and weight on etanercept efficacy in patients with psoriasis: A retrospective study.

Giunta A, Babino G, Ruzzetti M, Manetta S, Chimenti S, Esposito M.

J Int Med Res. 2016 Sep;44(1 suppl):72-75.

16.

Biosimilars for psoriasis: clinical studies to determine similarity.

Blauvelt A, Puig L, Chimenti S, Vender R, Rajagopalan M, Romiti R, Skov L, Zachariae C, Young H, Prens E, Cohen A, van der Walt J, Wu JJ.

Br J Dermatol. 2017 Jul;177(1):23-33. doi: 10.1111/bjd.15067. Epub 2017 May 28. Review.

PMID:
27639072
17.

Quality of life and patient benefit following transition from methotrexate to ustekinumab in psoriasis.

Augustin M, Blome C, Paul C, Puig L, Luger T, Lambert J, Chimenti S, Girolomoni G, Kragballe K, Naessens D, Bergmans P, Smirnov P, Barker J, Reich K.

J Eur Acad Dermatol Venereol. 2017 Feb;31(2):294-303. doi: 10.1111/jdv.13823. Epub 2016 Aug 12.

PMID:
27515070
18.

Pharmacodynamic assessment of apremilast for the treatment of moderate-to-severe plaque psoriasis.

Bianchi L, Del Duca E, Romanelli M, Saraceno R, Chimenti S, Chiricozzi A.

Expert Opin Drug Metab Toxicol. 2016 Sep;12(9):1121-8. doi: 10.1080/17425255.2016.1206886. Epub 2016 Jul 14. Review.

PMID:
27376729
19.

Real-life 9-year experience with adalimumab in psoriasis and psoriatic arthritis: results of a single-centre, retrospective study.

Chiricozzi A, Zangrilli A, Bavetta M, Bianchi L, Chimenti S, Saraceno R.

J Eur Acad Dermatol Venereol. 2017 Feb;31(2):304-311. doi: 10.1111/jdv.13771. Epub 2016 Jun 21.

PMID:
27324646
20.

Tofacitinib for the treatment of psoriasis.

Galluzzo M, D'Adamio S, Servoli S, Bianchi L, Chimenti S, Talamonti M.

Expert Opin Pharmacother. 2016 Jul;17(10):1421-33. doi: 10.1080/14656566.2016.1195812. Review.

PMID:
27267933
21.

Small molecules and antibodies for the treatment of psoriasis: a patent review (2010-2015).

Chiricozzi A, Saraceno R, Novelli L, Fida M, Caso F, Scarpa R, Costa L, Perricone R, Romanelli M, Chimenti S, Chimenti MS.

Expert Opin Ther Pat. 2016 Jul;26(7):757-66. doi: 10.1080/13543776.2016.1192129. Epub 2016 Jun 13. Review.

PMID:
27266423
22.

Age and hypertension strongly induce aortic stiffening in rats at basal and matched blood pressure levels.

Lindesay G, Ragonnet C, Chimenti S, Villeneuve N, Vayssettes-Courchay C.

Physiol Rep. 2016 May;4(10). pii: e12805. doi: 10.14814/phy2.12805.

23.

UVA1 Laser in the Treatment of Vitiligo.

Babino G, Giunta A, Esposito M, Saraceno R, Pavlidis A, Del Duca E, Chimenti S, Nisticò SP.

Photomed Laser Surg. 2016 May;34(5):200-4. doi: 10.1089/pho.2015.4004. Epub 2016 Apr 12.

PMID:
27070209
24.

Long-term use of a new topical formulation containing piroxicam 0.8% and sunscreen: efficacy and tolerability on actinic keratosis. A proof of concept study.

Babino G, Diluvio L, Bianchi L, Orlandi A, Di Prete M, Chimenti S, Milani M, Campione E.

Curr Med Res Opin. 2016 Aug;32(8):1345-9. doi: 10.1080/03007995.2016.1174678. Epub 2016 Apr 15.

PMID:
27046744
25.

HLA-C*18:01: A Rare Allele in the European Caucasian Population Coinciding with Difficult-to-Treat Plaque Psoriasis.

Galluzzo M, Andreani M, Testi M, Chimenti S, Talamonti M.

Mol Diagn Ther. 2016 Jun;20(3):227-30. doi: 10.1007/s40291-016-0199-y.

PMID:
27038214
26.

Lack of efficacy of imiquimod in patients with basal cell carcinoma previously treated with rituximab for B cell lymphoma: two case reports.

Campione E, Di Prete M, Del Principe I, Diluvio L, Citarella L, Orlandi A, Chimenti S, Bianchi L.

J Med Case Rep. 2016 Mar 11;10:57. doi: 10.1186/s13256-016-0834-6.

27.

SBP, DBP, and pulse blood pressure variability are temporally associated with the increase in pulse wave velocity in a model of aortic stiffness.

Isabelle M, Chimenti S, Beaussier H, Gransagne D, Villeneuve N, Safar ME, Duchatelle V, Vilaine JP, Vayssettes-Courchay C, Bézie Y.

J Hypertens. 2016 Apr;34(4):666-75. doi: 10.1097/HJH.0000000000000838.

PMID:
26938811
28.

Serum Protein Profile Changes in Psoriatic Patients Undergoing Treatment With Infliximab.

Chiricozzi A, Specchio F, Dattola A, Fida M, Bianchi L, Chimenti S, Saraceno R.

J Drugs Dermatol. 2016 Feb;15(2):134-8.

PMID:
26885779
29.

Efficacy of cyclosporine A as monotherapy in patients with psoriatic arthritis: a subgroup analysis of the SYNERGY Study.

Colombo D, Chimenti S, Grossi PA, Marchesoni A, Foti R, Calzavara-Pinton P, Zagni E, Ori A, Bellia G; SYNERGY Study Group.

G Ital Dermatol Venereol. 2017 Jun;152(3):297-301. doi: 10.23736/S0392-0488.16.05301-3. Epub 2016 Feb 2.

PMID:
26837484
30.

HLA-C*06 and response to ustekinumab in Caucasian patients with psoriasis: Outcome and long-term follow-up.

Talamonti M, Galluzzo M, Chimenti S, Costanzo A.

J Am Acad Dermatol. 2016 Feb;74(2):374-5. doi: 10.1016/j.jaad.2015.08.055. No abstract available.

PMID:
26775778
31.

Rhodamine intense pulsed light versus conventional intense pulsed light for facial telangiectasias.

Piccolo D, Crisman G, Kostaki D, Cannarozzo G, Sannino M, Chimenti S.

J Cosmet Laser Ther. 2016;18(2):80-5. doi: 10.3109/14764172.2015.1114641. Epub 2016 Feb 25.

PMID:
26736070
32.
33.

A new therapeutic for the treatment of moderate-to-severe plaque psoriasis: apremilast.

Chiricozzi A, Caposiena D, Garofalo V, Cannizzaro MV, Chimenti S, Saraceno R.

Expert Rev Clin Immunol. 2016;12(3):237-49. doi: 10.1586/1744666X.2016.1134319.

PMID:
26692125
34.

IL12B (p40) Gene Polymorphisms Contribute to Ustekinumab Response Prediction in Psoriasis.

Galluzzo M, Boca AN, Botti E, Potenza C, Malara G, Malagoli P, Vesa S, Chimenti S, Buzoianu AD, Talamonti M, Costanzo A.

Dermatology. 2016;232(2):230-6. doi: 10.1159/000441719. Epub 2015 Dec 18.

35.

New therapeutic approaches in the treatment of anogenital lichen sclerosus: does photodynamic therapy represent a novel option?

Criscuolo AA, Schipani C, Cannizzaro MV, Messinese S, Chimenti S, Piccione E, Saraceno R.

G Ital Dermatol Venereol. 2017 Apr;152(2):117-121. doi: 10.23736/S0392-0488.16.05272-X. Epub 2015 Dec 3.

PMID:
26632959
36.

Hidradenitis suppurativa: guidelines of the Italian Society of Dermatology and Venereology (SIDeMaST) for the use of anti-TNF-α agents.

Megna M, Bettoli V, Chimenti S, Chiricozzi A, Naldi L, Virgili A, Girolomoni G, Monfrecola G.

G Ital Dermatol Venereol. 2015 Dec;150(6):731-9.

PMID:
26513043
37.

AISI: A New Disease Severity Assessment Tool for Hidradenitis Suppurativa.

Chiricozzi A, Faleri S, Franceschini C, Caro RD, Chimenti S, Bianchi L.

Wounds. 2015 Oct;27(10):258-64.

38.

Atopic dermatitis and dental manifestations.

Perugia C, Saraceno R, Ventura A, Lorè B, Chiaramonte C, Docimo R, Chimenti S.

G Ital Dermatol Venereol. 2017 Apr;152(2):122-125. doi: 10.23736/S0392-0488.16.05224-X. Epub 2015 Oct 7.

PMID:
26446571
39.

Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis.

Lebwohl M, Strober B, Menter A, Gordon K, Weglowska J, Puig L, Papp K, Spelman L, Toth D, Kerdel F, Armstrong AW, Stingl G, Kimball AB, Bachelez H, Wu JJ, Crowley J, Langley RG, Blicharski T, Paul C, Lacour JP, Tyring S, Kircik L, Chimenti S, Callis Duffin K, Bagel J, Koo J, Aras G, Li J, Song W, Milmont CE, Shi Y, Erondu N, Klekotka P, Kotzin B, Nirula A.

N Engl J Med. 2015 Oct;373(14):1318-28. doi: 10.1056/NEJMoa1503824.

40.

The impact of biologic therapy in chronic plaque psoriasis from a societal perspective: an analysis based on Italian actual clinical practice.

Polistena B, Calzavara-Pinton P, Altomare G, Berardesca E, Girolomoni G, Martini P, Peserico A, Puglisi Guerra A, Spandonaro F, Vena Gino A, Chimenti S, Ayala F.

J Eur Acad Dermatol Venereol. 2015 Dec;29(12):2411-6. doi: 10.1111/jdv.13307. Epub 2015 Sep 15.

PMID:
26370321
41.

Apremilast for the treatment of psoriasis.

Chimenti MS, Gramiccia T, Saraceno R, Bianchi L, Garofalo V, Buonomo O, Perricone R, Chimenti S, Chiricozzi A.

Expert Opin Pharmacother. 2015;16(13):2083-94. Epub 2015 Aug 4. Review.

PMID:
26243735
42.

Basal cell carcinoma: clinical and pathological features.

Di Stefani A, Chimenti S.

G Ital Dermatol Venereol. 2015 Aug;150(4):385-91. Epub 2015 Jun 23.

PMID:
26099353
43.

Cyclosporine: a novel therapeutic approach for Burning Mouth Syndrome.

Saraceno R, Lorè B, Pavlidis A, Karaiskou M, Arcuri C, Chimenti S, Magnato R.

G Ital Dermatol Venereol. 2016 Oct;151(5):480-4. Epub 2015 Jun 19.

PMID:
26091275
44.

Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1).

Papp K, Reich K, Leonardi CL, Kircik L, Chimenti S, Langley RG, Hu C, Stevens RM, Day RM, Gordon KB, Korman NJ, Griffiths CE.

J Am Acad Dermatol. 2015 Jul;73(1):37-49. doi: 10.1016/j.jaad.2015.03.049.

45.

Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial.

Bachelez H, van de Kerkhof PC, Strohal R, Kubanov A, Valenzuela F, Lee JH, Yakusevich V, Chimenti S, Papacharalambous J, Proulx J, Gupta P, Tan H, Tawadrous M, Valdez H, Wolk R; OPT Compare Investigators.

Lancet. 2015 Aug 8;386(9993):552-61. doi: 10.1016/S0140-6736(14)62113-9. Epub 2015 Jun 4.

PMID:
26051365
46.

Linear psoriasis following the typical distribution of the sciatic nerve.

Galluzzo M, Talamonti M, Di Stefani A, Chimenti S.

J Dermatol Case Rep. 2015 Mar 31;9(1):6-11. doi: 10.3315/jdcr.2015.1189. eCollection 2015 Mar 31.

47.

Psoriasis Phenotype in Inflammatory Bowel Disease: A Case-Control Prospective Study.

Lolli E, Saraceno R, Calabrese E, Ascolani M, Scarozza P, Chiricozzi A, Onali S, Petruzziello C, Chimenti S, Pallone F, Biancone L.

J Crohns Colitis. 2015 Sep;9(9):699-707. doi: 10.1093/ecco-jcc/jjv068. Epub 2015 Apr 23.

PMID:
25908719
48.

Aphthous, celiac disease and other dental disorders in childhood.

Saraceno R, Perugia C, Ventura A, LORè B, Chimenti S, Docimo R.

G Ital Dermatol Venereol. 2016 Jun;151(3):239-43. Epub 2015 Apr 9.

PMID:
25854669
49.

Cyclosporine in psoriasis: comparison of a 25-year real-world Italian experience to current European guidelines.

Altomare G, Ayala F, Bardazzi F, Bellia G, Chimenti S, Colombo D, Flori ML, Girolomoni G, Micali G, Parodi A, Peris K, Vena GA.

G Ital Dermatol Venereol. 2016 Aug;151(4):432-5. Epub 2015 Mar 19.

PMID:
25786483
50.

Tazarotene as alternative topical treatment for onychomycosis.

Campione E, Paternò EJ, Costanza G, Diluvio L, Carboni I, Marino D, Favalli C, Chimenti S, Bianchi L, Orlandi A.

Drug Des Devel Ther. 2015 Feb 16;9:879-86. doi: 10.2147/DDDT.S69946. eCollection 2015.

Supplemental Content

Loading ...
Support Center